| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A DNAH2 CHD9 CHD8 AK9 CHD7 RAD50 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNAH11 | 1.01e-08 | 441 | 173 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A ATP6V1E2 DNAH2 CHD9 CHD8 AK9 CHD7 RAD50 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNAH11 | 8.77e-08 | 614 | 173 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A DNAH2 CHD9 CHD8 AK9 CHD7 RAB20 RAD50 EEF2 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 1.02e-06 | 775 | 173 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A DNAH2 CHD9 CHD8 AK9 NUDT16L1 CHD7 RAB20 RAD50 EEF2 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 1.03e-06 | 839 | 173 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A DNAH2 CHD9 CHD8 AK9 NUDT16L1 CHD7 RAB20 RAD50 EEF2 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 1.05e-06 | 840 | 173 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 SMC1A DNAH2 CHD9 CHD8 AK9 NUDT16L1 CHD7 RAB20 RAD50 EEF2 DDX53 CHD6 DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 1.05e-06 | 840 | 173 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | helicase activity | 1.22e-06 | 158 | 173 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 6.31e-06 | 5 | 173 | 3 | GO:0004558 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.18e-05 | 7 | 173 | 3 | GO:0090599 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 5.17e-05 | 9 | 173 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 5.17e-05 | 9 | 173 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 7.46e-05 | 2 | 173 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | formate-tetrahydrofolate ligase activity | 7.46e-05 | 2 | 173 | 2 | GO:0004329 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.34e-04 | 129 | 173 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.17e-04 | 14 | 173 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | glucosidase activity | 2.69e-04 | 15 | 173 | 3 | GO:0015926 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.88e-04 | 37 | 173 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.52e-04 | 151 | 173 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 4.43e-04 | 4 | 173 | 2 | GO:0004486 | |
| GeneOntologyMolecularFunction | methylenetetrahydrofolate dehydrogenase (NADP+) activity | 4.43e-04 | 4 | 173 | 2 | GO:0004488 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.44e-04 | 127 | 173 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 8.72e-04 | 22 | 173 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.13e-03 | 24 | 173 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 1.28e-03 | 25 | 173 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | DDX59 ERN1 RTEL1 CHD9 CHD8 NUDT16L1 CHD7 RNASE13 RAD50 POLR1B DDX53 CHD6 DDX60L DDX41 | 1.51e-03 | 645 | 173 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 1.60e-03 | 27 | 173 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | DCAF1 ILK ERN1 BMP2K RPS6KA2 PAK4 KSR2 KSR1 BRD2 MTOR STKLD1 | 1.81e-03 | 446 | 173 | 11 | GO:0004674 |
| GeneOntologyBiologicalProcess | negative regulation of neural precursor cell proliferation | 1.01e-05 | 35 | 172 | 5 | GO:2000178 | |
| Domain | P-loop_NTPase | TANC2 MYH1 MYH7 DDX59 SPAST VWA8 RTEL1 ABCA12 MTHFD1L SMC1A DNAH2 CHD9 CHD8 AK9 CHD7 RAB20 RAD50 EEF2 MTHFD1 DLG2 DDX53 CHD6 IFI44L DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 7.69e-09 | 848 | 177 | 28 | IPR027417 |
| Domain | - | DDX59 SPAST VWA8 RTEL1 ABCA12 MTHFD1L SMC1A DNAH2 CHD9 CHD8 AK9 CHD7 RAB20 RAD50 EEF2 MTHFD1 DLG2 DDX53 CHD6 IFI44L DDX60L DDX41 FIGNL1 DNM2 DNAH11 | 4.03e-08 | 746 | 177 | 25 | 3.40.50.300 |
| Domain | BRK | 1.15e-07 | 6 | 177 | 4 | SM00592 | |
| Domain | BRK_domain | 1.15e-07 | 6 | 177 | 4 | IPR006576 | |
| Domain | BRK | 1.15e-07 | 6 | 177 | 4 | PF07533 | |
| Domain | ARM-type_fold | DCAF1 HGH1 FHOD3 KIFAP3 JUP CSE1L NF1 CNOT9 MTOR NOM1 DIAPH1 PUM3 STKLD1 ARMC8 XPOT | 8.61e-07 | 339 | 177 | 15 | IPR016024 |
| Domain | ARM-like | DCAF1 HGH1 FHOD3 KIFAP3 JUP CSE1L NF1 CNOT9 MTOR PUM3 STKLD1 ARMC8 XPOT | 1.88e-06 | 270 | 177 | 13 | IPR011989 |
| Domain | Gal_mutarotase_N | 3.32e-06 | 4 | 177 | 3 | IPR031727 | |
| Domain | NtCtMGAM_N | 3.32e-06 | 4 | 177 | 3 | PF16863 | |
| Domain | Bromodomain_CS | 4.04e-06 | 26 | 177 | 5 | IPR018359 | |
| Domain | Helicase_C | 8.15e-06 | 107 | 177 | 8 | PF00271 | |
| Domain | HELICc | 8.15e-06 | 107 | 177 | 8 | SM00490 | |
| Domain | Helicase_C | 8.73e-06 | 108 | 177 | 8 | IPR001650 | |
| Domain | - | 9.06e-06 | 222 | 177 | 11 | 1.25.10.10 | |
| Domain | HELICASE_CTER | 9.35e-06 | 109 | 177 | 8 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.35e-06 | 109 | 177 | 8 | PS51192 | |
| Domain | DEXDc | 9.35e-06 | 109 | 177 | 8 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.00e-05 | 110 | 177 | 8 | IPR014001 | |
| Domain | Ion_trans_dom | 1.30e-05 | 114 | 177 | 8 | IPR005821 | |
| Domain | Ion_trans | 1.30e-05 | 114 | 177 | 8 | PF00520 | |
| Domain | Glyco_hydro_31_AS | 1.64e-05 | 6 | 177 | 3 | IPR030458 | |
| Domain | Gal_mutarotase_SF_dom | 1.69e-05 | 17 | 177 | 4 | IPR011013 | |
| Domain | BROMODOMAIN_1 | 2.46e-05 | 37 | 177 | 5 | PS00633 | |
| Domain | Bromodomain | 2.81e-05 | 38 | 177 | 5 | PF00439 | |
| Domain | Glyco_hydro_31 | 2.85e-05 | 7 | 177 | 3 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.85e-05 | 7 | 177 | 3 | PF01055 | |
| Domain | Ca_chan_IQ | 2.85e-05 | 7 | 177 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.85e-05 | 7 | 177 | 3 | PF08763 | |
| Domain | VDCC_a1su_IQ | 2.85e-05 | 7 | 177 | 3 | IPR014873 | |
| Domain | GPHH | 2.85e-05 | 7 | 177 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.85e-05 | 7 | 177 | 3 | IPR031649 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.85e-05 | 7 | 177 | 3 | PS00129 | |
| Domain | BROMODOMAIN_2 | 4.11e-05 | 41 | 177 | 5 | PS50014 | |
| Domain | Trefoil | 4.53e-05 | 8 | 177 | 3 | PF00088 | |
| Domain | Bromodomain | 4.63e-05 | 42 | 177 | 5 | IPR001487 | |
| Domain | BROMO | 4.63e-05 | 42 | 177 | 5 | SM00297 | |
| Domain | - | 4.63e-05 | 42 | 177 | 5 | 1.20.920.10 | |
| Domain | P_TREFOIL_2 | 6.74e-05 | 9 | 177 | 3 | PS51448 | |
| Domain | PD | 6.74e-05 | 9 | 177 | 3 | SM00018 | |
| Domain | Chromo_domain | 7.14e-05 | 24 | 177 | 4 | IPR023780 | |
| Domain | Formate_THF_ligase | 8.93e-05 | 2 | 177 | 2 | IPR000559 | |
| Domain | KSR1-SAM | 8.93e-05 | 2 | 177 | 2 | PF13543 | |
| Domain | FTHFS_2 | 8.93e-05 | 2 | 177 | 2 | PS00722 | |
| Domain | FTHFS_1 | 8.93e-05 | 2 | 177 | 2 | PS00721 | |
| Domain | FTHFS | 8.93e-05 | 2 | 177 | 2 | PF01268 | |
| Domain | Formate_THF_ligase_CS | 8.93e-05 | 2 | 177 | 2 | IPR020628 | |
| Domain | KSR_SAM-like_dom | 8.93e-05 | 2 | 177 | 2 | IPR025561 | |
| Domain | VDCCAlpha1 | 9.56e-05 | 10 | 177 | 3 | IPR002077 | |
| Domain | Chromo | 9.90e-05 | 26 | 177 | 4 | PF00385 | |
| Domain | - | 1.31e-04 | 11 | 177 | 3 | 4.10.110.10 | |
| Domain | CHROMO_1 | 1.34e-04 | 28 | 177 | 4 | PS00598 | |
| Domain | CHROMO_2 | 1.34e-04 | 28 | 177 | 4 | PS50013 | |
| Domain | P_trefoil_dom | 1.73e-04 | 12 | 177 | 3 | IPR000519 | |
| Domain | SNF2_N | 2.28e-04 | 32 | 177 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.28e-04 | 32 | 177 | 4 | PF00176 | |
| Domain | Chromodomain-like | 2.28e-04 | 32 | 177 | 4 | IPR016197 | |
| Domain | Chromo/shadow_dom | 2.57e-04 | 33 | 177 | 4 | IPR000953 | |
| Domain | CHROMO | 2.57e-04 | 33 | 177 | 4 | SM00298 | |
| Domain | ATPase_dyneun-rel_AAA | 2.82e-04 | 14 | 177 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.82e-04 | 14 | 177 | 3 | PF07728 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.25e-04 | 35 | 177 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.47e-04 | 38 | 177 | 4 | PS00690 | |
| Domain | AAA | 4.51e-04 | 144 | 177 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 4.51e-04 | 144 | 177 | 7 | IPR003593 | |
| Domain | BET | 5.29e-04 | 4 | 177 | 2 | PF17035 | |
| Domain | THF_DHG_CYH_C | 5.29e-04 | 4 | 177 | 2 | PF02882 | |
| Domain | Glyco_hydro_31_CS | 5.29e-04 | 4 | 177 | 2 | IPR030459 | |
| Domain | THF_DH/CycHdrlase_cat_dom | 5.29e-04 | 4 | 177 | 2 | IPR020630 | |
| Domain | THF_DH/CycHdrlase_NAD-bd_dom | 5.29e-04 | 4 | 177 | 2 | IPR020631 | |
| Domain | TRPM_tetra | 5.29e-04 | 4 | 177 | 2 | PF16519 | |
| Domain | THF_DHG_CYH | 5.29e-04 | 4 | 177 | 2 | PF00763 | |
| Domain | THF_DH/CycHdrlase | 5.29e-04 | 4 | 177 | 2 | IPR000672 | |
| Domain | TRPM_tetra | 5.29e-04 | 4 | 177 | 2 | IPR032415 | |
| Domain | NET_dom | 5.29e-04 | 4 | 177 | 2 | IPR027353 | |
| Domain | NET | 5.29e-04 | 4 | 177 | 2 | PS51525 | |
| Domain | PDEase | 7.25e-04 | 19 | 177 | 3 | IPR023088 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 8.76e-04 | 5 | 177 | 2 | PS00707 | |
| Domain | RDM_domain_RFPL | 8.76e-04 | 5 | 177 | 2 | IPR022723 | |
| Domain | RDM | 8.76e-04 | 5 | 177 | 2 | PF11002 | |
| Domain | PDEase_I | 9.82e-04 | 21 | 177 | 3 | PF00233 | |
| Domain | PDEASE_I | 9.82e-04 | 21 | 177 | 3 | PS00126 | |
| Domain | PDEase_CS | 9.82e-04 | 21 | 177 | 3 | IPR023174 | |
| Domain | - | 1.13e-03 | 22 | 177 | 3 | 1.10.1300.10 | |
| Domain | PDEase_catalytic_dom | 1.29e-03 | 23 | 177 | 3 | IPR002073 | |
| Domain | HD/PDEase_dom | 1.46e-03 | 24 | 177 | 3 | IPR003607 | |
| Domain | HDc | 1.46e-03 | 24 | 177 | 3 | SM00471 | |
| Domain | Rab_bind | 1.82e-03 | 7 | 177 | 2 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.82e-03 | 7 | 177 | 2 | IPR032023 | |
| Domain | GAF | 1.82e-03 | 7 | 177 | 2 | PF01590 | |
| Domain | Channel_four-helix_dom | 2.08e-03 | 57 | 177 | 4 | IPR027359 | |
| Domain | - | 2.08e-03 | 57 | 177 | 4 | 1.20.120.350 | |
| Domain | ERAP1-like_C_dom | 2.41e-03 | 8 | 177 | 2 | IPR024571 | |
| Domain | DAD_dom | 2.41e-03 | 8 | 177 | 2 | IPR014767 | |
| Domain | DHC_N1 | 2.41e-03 | 8 | 177 | 2 | PF08385 | |
| Domain | DAD | 2.41e-03 | 8 | 177 | 2 | PS51231 | |
| Domain | GAF | 2.41e-03 | 8 | 177 | 2 | IPR003018 | |
| Domain | P_TREFOIL_1 | 2.41e-03 | 8 | 177 | 2 | PS00025 | |
| Domain | Vps4_C | 2.41e-03 | 8 | 177 | 2 | IPR015415 | |
| Domain | Vps4_C | 2.41e-03 | 8 | 177 | 2 | PF09336 | |
| Domain | ERAP1_C | 2.41e-03 | 8 | 177 | 2 | PF11838 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 6.32e-05 | 9 | 131 | 3 | M47622 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 7.20e-05 | 47 | 131 | 5 | M19708 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.23e-04 | 11 | 131 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.23e-04 | 11 | 131 | 3 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.23e-04 | 11 | 131 | 3 | M47958 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 ILK NOP56 RPS2 MTHFD1L NPEPPS SMC1A RPS10 LRRC40 CHD8 CHD7 PRPF8 ADAR ERBIN NUP205 RAD50 JUP EEF2 CSE1L NF1 UBN1 TCERG1 MTHFD1 RBM19 ARHGEF1 AHNAK DIAPH1 POLR1B PUM3 DDX60L DDX41 PCID2 XPOT | 9.19e-14 | 1353 | 179 | 33 | 29467282 |
| Pubmed | RGPD4 TANC2 CACNA1A CACNA1E IQSEC3 NOP56 NPEPPS RPS6KA2 KSR2 RGPD1 CHD8 CHD7 ZNF318 ERBIN STRIP1 RAD50 EEF2 AP1S1 PBRM1 NF1 UBE2V2 MTOR DIAPH1 DLG2 CAMSAP2 DNM2 ARMC8 | 8.79e-13 | 963 | 179 | 27 | 28671696 | |
| Pubmed | RPS2 MTHFD1L NPEPPS UGGT1 RPS10 CHD8 CHD7 ZNF318 PRPF8 NUP205 ITPR3 RAD50 PBRM1 CSE1L NF1 MTOR AHNAK PUM3 DNM2 XPOT | 2.15e-10 | 653 | 179 | 20 | 22586326 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 SF3B4 ILK SMC1A PAK4 LRRC40 CHD8 CHD7 PRPF8 RAD50 CSE1L NF1 BRD2 UBN1 ARHGEF1 AHNAK DIAPH1 DDX41 DNM2 | 2.16e-10 | 582 | 179 | 19 | 20467437 |
| Pubmed | ILK NOP56 ERAP1 RPS2 MTHFD1L RPS10 LRRC40 PRPF8 ADAR EXOC8 NUP205 ITPR3 RAD50 KSR1 EEF2 AP1S1 CSE1L NF1 CNOT9 MTHFD1 MTOR RBM19 AHNAK DDX41 PLSCR1 GAA | 3.70e-10 | 1168 | 179 | 26 | 19946888 | |
| Pubmed | SF3B4 NOP56 RPS2 SMC1A RPS10 LRRC40 PRPF8 ADAR NUP205 RAD50 EEF2 CSE1L TCERG1 MTHFD1 MTOR DIAPH1 DDX41 DNM2 XPOT | 9.92e-10 | 638 | 179 | 19 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SF3B4 NOP56 BMP2K RPS2 MTHFD1L SMC1A LRRC40 CHD8 NUDT16L1 CHD7 PRPF8 ADAR NUP205 EEF2 AP1S1 PBRM1 TCERG1 MTHFD1 ARHGEF1 AHNAK DIAPH1 POLR1B CHD6 DDX41 PCID2 DNM2 XPOT | 1.00e-09 | 1318 | 179 | 27 | 30463901 |
| Pubmed | EPC2 DDX59 NOP56 MED29 NPEPPS IFT81 RPS10 BRD3 ERBIN RAD50 KAT2B PBRM1 BRD2 UBN1 AHNAK DIAPH1 PUM3 CHD6 BRD1 | 1.19e-09 | 645 | 179 | 19 | 25281560 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOP56 TRIM4 RPS2 MTHFD1L NPEPPS SMC1A UGGT1 RPS10 LRRC40 PRPF8 ADAR NUP205 RAD50 JUP EEF2 PBRM1 CSE1L NF1 TCERG1 MTHFD1 MTOR RBM19 DIAPH1 PUM3 DDX41 MGAM2 ARMC8 XPOT | 1.19e-09 | 1425 | 179 | 28 | 30948266 |
| Pubmed | ILK NOP56 RPS2 SMC1A RPS10 PRPF8 ADAR RAD50 JUP EEF2 BRD2 MTHFD1 NOM1 ARHGEF1 AHNAK DDX41 DNM2 XPOT | 2.57e-09 | 601 | 179 | 18 | 33658012 | |
| Pubmed | NOP56 TRIM4 SMC1A CHD8 BRD3 CHD7 NUP205 RAD50 PBRM1 CSE1L BRD2 NOM1 AHNAK CHD6 MAD2L2 ARMC8 | 3.31e-09 | 469 | 179 | 16 | 27634302 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOP56 RPS2 NPEPPS SMC1A UGGT1 RPS10 LRRC40 NUDT16L1 ZNF318 PRPF8 ADAR NUP205 ITPR3 RAD50 JUP PBRM1 CSE1L NF1 BRD2 MTHFD1 AHNAK PUM3 DDX41 | 3.56e-09 | 1024 | 179 | 23 | 24711643 |
| Pubmed | VWA8 MTHFD1L NPEPPS SMC1A IFT81 UGGT1 LRRC40 PRPF8 ADAR EXOC8 RAD50 CSE1L TCERG1 DIAPH1 PCID2 DNM2 XPOT | 5.96e-09 | 560 | 179 | 17 | 35241646 | |
| Pubmed | NOP56 BMP2K VWA8 MTHFD1L NPEPPS UGGT1 PRPF8 ERBIN NUP205 ITPR3 RAD50 ANKRD13A MYOF EEF2 CSE1L UBN1 CNOT9 MTOR NOM1 AHNAK PUM3 IFI44L DDX60L DDX41 FIGNL1 ARMC8 XPOT | 6.57e-09 | 1440 | 179 | 27 | 30833792 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SF3B4 NOP56 RPS2 SMC1A UGGT1 RPS10 PRPF8 ADAR NUP205 ITPR3 RAD50 MICU1 MYOF JUP EEF2 CSE1L TCERG1 MTHFD1 RBM19 NOM1 AHNAK POLR1B PUM3 DDX41 DMTN | 8.01e-09 | 1257 | 179 | 25 | 36526897 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | LGMN MAN2B2 NOP56 MTHFD1L NPEPPS UGGT1 PRPF8 MYOF CSE1L TCERG1 MTHFD1 DIAPH1 DNM2 | 3.16e-08 | 344 | 179 | 13 | 30333137 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NOP56 HGH1 TOPAZ1 MTHFD1L NPEPPS IFT81 PCDHB6 CHD9 BRD3 AK9 PRPF8 PTPRB KIAA0825 MTHFD1 XPOT | 5.24e-08 | 497 | 179 | 15 | 36774506 |
| Pubmed | EPC2 SPAST ILK TRIM4 MED29 NPEPPS SMC1A CHD9 CHD8 NUDT16L1 CHD7 ZNF318 ADAR RAD50 EEF2 TCERG1 MTHFD1 PUM3 DDX41 TBCA DNM2 XPOT | 6.51e-08 | 1103 | 179 | 22 | 34189442 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX59 SF3B4 ILK NOP56 VWA8 RPS2 MTHFD1L SMC1A UGGT1 RPS10 LRRC40 PRPF8 RAD50 JUP EEF2 CSE1L TCERG1 CNOT9 MTHFD1 RBM19 ARHGEF1 AHNAK DIAPH1 DDX41 XPOT | 7.94e-08 | 1415 | 179 | 25 | 28515276 |
| Pubmed | 8.50e-08 | 197 | 179 | 10 | 31620119 | ||
| Pubmed | RGPD4 CACNA1E MYH1 SCN11A MYH7 NOP56 IFT81 UGGT1 DNAH2 RGPD1 BRD3 ZNF318 PRPF8 ERBIN NUP205 EEF2 BRD2 KIAA0825 AHNAK ANKRD30A DLG2 CHD6 CAMSAP2 PCID2 SLC6A14 | 1.14e-07 | 1442 | 179 | 25 | 35575683 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 38996073 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 28533432 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.34e-07 | 3 | 179 | 3 | 24523520 | |
| Pubmed | LGMN ILK MAN2B2 NPEPPS SMC1A UGGT1 RPS10 PRPF8 ADAR NUP205 RAD50 CSE1L MTHFD1 GAA DNM2 XPOT | 1.35e-07 | 613 | 179 | 16 | 22268729 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 NOP56 RPS2 MTHFD1L SMC1A RPS10 PRPF8 ADAR ERBIN NUP205 RAD50 JUP EEF2 BRD2 TCERG1 MTHFD1 RBM19 AHNAK PUM3 DDX41 | 2.17e-07 | 989 | 179 | 20 | 36424410 |
| Pubmed | FAM184A BMP2K MTHFD1L CHD8 BRD3 CHD7 ZNF318 ERBIN STRIP1 MICU1 MYOF PBRM1 BRD2 TCERG1 CNOT9 MTHFD1 RBM19 NOM1 MTFR1 POLR1B PUM3 CHD6 CAMSAP2 PCID2 ARMC8 | 2.29e-07 | 1497 | 179 | 25 | 31527615 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | NOP56 RPS2 MTHFD1L NPEPPS RPS10 ADAR EEF2 MTHFD1 PIK3R2 NOM1 POLR1B FIGNL1 GAA DNM2 XPOT | 2.72e-07 | 565 | 179 | 15 | 33567341 |
| Pubmed | DCAF1 TANC2 EPC2 TRIM4 VWA8 ABCA12 CHD9 CHD8 BRD3 ZNF318 TNFRSF10B RAD50 KSR1 KAT2B PBRM1 BRD2 PIK3R2 DIAPH1 BRD1 DDX41 PCID2 | 3.45e-07 | 1116 | 179 | 21 | 31753913 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 TANC2 SMC1A IFT81 PAK4 PRPF8 EXOC8 NUP205 RAD50 MICU1 ANKRD13A KIFAP3 KSR1 CSE1L NF1 CNOT9 UBE2V2 MTOR AHNAK DDX41 CAMSAP2 DNM2 ARMC8 | 3.56e-07 | 1321 | 179 | 23 | 27173435 |
| Pubmed | EPC2 KLF12 NOP56 SMC1A RPS10 RGPD1 R3HDM2 CHD8 CHD7 ZNF318 ERBIN NUP205 RAD50 JUP KAT2B PBRM1 CSE1L BRD2 UBN1 TCERG1 CNOT9 PUM3 CHD6 XPOT | 3.70e-07 | 1429 | 179 | 24 | 35140242 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 TANC2 CACNA1B CACNA1E IQSEC3 NOP56 RPS2 RGPD1 EEF2 DMTN | 3.72e-07 | 231 | 179 | 10 | 16452087 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 ILK NOP56 MTHFD1L NPEPPS SMC1A RPS10 RGPD1 BRD3 PRPF8 CSE1L BRD2 ARHGEF1 RPS10P5 DDX41 GAA | 3.99e-07 | 665 | 179 | 16 | 30457570 |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 22211741 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 5.34e-07 | 4 | 179 | 3 | 37141091 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 5.34e-07 | 4 | 179 | 3 | 32616470 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SF3B4 NOP56 SMC1A RPS10 CHD8 CHD7 ZNF318 PRPF8 ADAR JUP EEF2 BRD2 UBN1 TCERG1 RBM19 AHNAK PUM3 RPS10P5 DDX41 | 5.59e-07 | 954 | 179 | 19 | 36373674 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 SF3B4 SPAST ILK RPS6KA2 PAK4 ERBIN KSR1 JUP NF1 TCERG1 MTOR ARHGEF1 AHNAK BRD1 DDX41 CAMSAP2 DMTN | 5.66e-07 | 861 | 179 | 18 | 36931259 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOP56 RPS2 SMC1A RPS10 PRPF8 ADAR JUP PBRM1 CSE1L BRD2 RBM19 NOM1 PUM3 BRD1 DDX41 | 6.43e-07 | 605 | 179 | 15 | 28977666 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SF3B4 PDPR ILK ERAP1 RPS2 MTHFD1L NPEPPS UGGT1 RPS10 PRPF8 ADAR ERBIN NUP205 RAD50 ANKRD13A MYOF JUP EEF2 MTOR RBM19 AHNAK GAA TBCA | 6.43e-07 | 1367 | 179 | 23 | 32687490 |
| Pubmed | RPS2 MTHFD1L NPEPPS SMC1A RPS10 PRPF8 NUP205 EEF2 CSE1L MTHFD1 NOM1 XPOT | 7.99e-07 | 383 | 179 | 12 | 29331416 | |
| Pubmed | ILK RPS2 MTHFD1L SMC1A RPS10 LRRC40 CHD8 ADAR NUP205 RAD50 MTHFD1 POLR1B TBCA DNM2 | 7.99e-07 | 534 | 179 | 14 | 35032548 | |
| Pubmed | 8.49e-07 | 195 | 179 | 9 | 19454010 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MKKS MYH7 SF3B4 ILK NOP56 MTHFD1L NPEPPS SMC1A UGGT1 PAK4 RPS10 PRPF8 STRIP1 NUP205 RAD50 JUP AP1S1 MTHFD1 NOM1 BCAR3 DDX41 PCID2 | 8.54e-07 | 1284 | 179 | 22 | 17353931 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPC2 SF3B4 NOP56 MED29 RPS2 SMC1A RPS10 BRD3 CHD7 ZNF318 PRPF8 ADAR ITPR3 RAD50 PBRM1 BRD2 UBN1 TCERG1 NOM1 AHNAK CHD6 DDX41 | 9.70e-07 | 1294 | 179 | 22 | 30804502 |
| Pubmed | DDX59 SF3B4 NOP56 HGH1 ERAP1 RPS2 MTHFD1L UGGT1 PRPF8 ADAR MYOF JUP EEF2 MTHFD1 ARHGEF1 AHNAK DIAPH1 NAA30 PCID2 GAA DNM2 XPOT | 1.01e-06 | 1297 | 179 | 22 | 33545068 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | NOP56 SMC1A CHD9 CHD8 BRD3 CHD7 PBRM1 CSE1L BRD2 AHNAK DDX41 DNM2 | 1.07e-06 | 394 | 179 | 12 | 27248496 |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 8825650 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 11296258 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 15451373 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ILK SMC1A CHD8 PRPF8 RAD50 EEF2 PBRM1 CSE1L TCERG1 MTHFD1 AHNAK | 1.35e-06 | 332 | 179 | 11 | 32786267 |
| Pubmed | MED29 SMC1A CHD9 CHD8 BRD3 PRPF8 ADAR NUP205 RAD50 EEF2 AP1S1 PBRM1 CSE1L BRD2 UBN1 TCERG1 AHNAK DIAPH1 DDX41 | 1.38e-06 | 1014 | 179 | 19 | 32416067 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 MYH1 MYH7 ERAP1 NPEPPS UGGT1 RGPD1 EXOC8 ANKRD13A EEF2 MTHFD1 MTOR AHNAK DNM2 XPOT | 1.48e-06 | 647 | 179 | 15 | 26618866 |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | LGMN SF3B4 ILK NOP56 RPS2 SMC1A PRPF8 EEF2 PBRM1 MTHFD1 PIK3R2 NOM1 DDX41 | 1.61e-06 | 486 | 179 | 13 | 30940648 |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.63e-06 | 109 | 179 | 7 | 33554859 | |
| Pubmed | NOP56 SMC1A RPS10 PRPF8 NUP205 RAD50 EEF2 RBM19 AHNAK POLR1B PUM3 | 1.71e-06 | 340 | 179 | 11 | 29478914 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | EPC2 CATIP MAN2B2 MTHFD1L CHD9 CHD7 ADAR ANKRD13A KIFAP3 KAT2B NF1 BRD2 CNOT9 MTOR PIK3R2 NOM1 ARHGEF1 DLG2 MAD2L2 PLSCR1 VWA5B1 | 1.90e-06 | 1242 | 179 | 21 | 30973865 |
| Pubmed | 1.91e-06 | 215 | 179 | 9 | 35973513 | ||
| Pubmed | NOP56 RPS2 SMC1A RPS10 NUDT16L1 ADAR RAD50 EEF2 TCERG1 RBM19 PUM3 DDX41 | 2.03e-06 | 419 | 179 | 12 | 15635413 | |
| Pubmed | TANC2 CACNA1A CACNA1B CACNA1E IQSEC3 STRIP1 AP1S1 C1orf198 NF1 DLG2 DMTN | 2.08e-06 | 347 | 179 | 11 | 17114649 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 SF3B4 NOP56 RPS2 NPEPPS SMC1A UGGT1 RPS10 PRPF8 ADAR RAD50 EEF2 CSE1L TCERG1 MTHFD1 AHNAK DIAPH1 DDX41 TBCA DNM2 | 2.20e-06 | 1149 | 179 | 20 | 35446349 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.22e-06 | 219 | 179 | 9 | 31353912 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RPS2 MTHFD1L NPEPPS SMC1A UGGT1 RPS10 RGPD1 PRPF8 NUP205 EEF2 CSE1L TCERG1 MTHFD1 NOM1 POLR1B RPS10P5 DDX41 PCID2 DNM2 XPOT | 2.30e-06 | 1257 | 179 | 21 | 37317656 |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 2.65e-06 | 6 | 179 | 3 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.65e-06 | 6 | 179 | 3 | 12827191 | |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 9238069 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SF3B4 NOP56 VWA8 RPS2 SMC1A RPS10 CHD9 BRD3 NUDT16L1 CHD7 PRPF8 ADAR NUP205 EEF2 CSE1L BRD2 TCERG1 CHD6 DDX41 | 3.54e-06 | 1082 | 179 | 19 | 38697112 |
| Pubmed | ILK BMP2K RPS2 RPS10 PRPF8 NUP205 EEF2 CSE1L TCERG1 MTHFD1 PIK3R2 ARHGEF1 AHNAK DIAPH1 DNM2 | 4.33e-06 | 707 | 179 | 15 | 19738201 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DCAF1 SF3B4 BMP2K RPS10 CHD8 TNFRSF10B PRPF8 STRIP1 EXOC8 NUP205 KIFAP3 JUP EEF2 PBRM1 CSE1L NOM1 AHNAK PLSCR1 PCID2 XPOT | 4.37e-06 | 1203 | 179 | 20 | 29180619 |
| Pubmed | Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. | 4.62e-06 | 7 | 179 | 3 | 25392995 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 4.62e-06 | 7 | 179 | 3 | 35176221 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | NOP56 TRIM4 RPS2 NPEPPS UGGT1 RPS10 CHD8 PRPF8 MYOF EEF2 CSE1L MTHFD1 AHNAK DIAPH1 DNM2 XPOT | 4.85e-06 | 807 | 179 | 16 | 30575818 |
| Pubmed | 5.23e-06 | 183 | 179 | 8 | 23956138 | ||
| Pubmed | DCAF1 ILK NOP56 BMP2K VWA8 ERAP1 UGGT1 ERBIN ITPR3 JUP PIK3R2 NOM1 PUM3 DNM2 | 5.82e-06 | 634 | 179 | 14 | 34591612 | |
| Pubmed | NOP56 MED29 RPS2 RGPD1 LRRC40 PRPF8 ERBIN KAT2B CNOT9 ARHGEF1 DNM2 | 6.32e-06 | 390 | 179 | 11 | 17643375 | |
| Pubmed | RGPD4 NOP56 RPS2 SMC1A RPS10 PRPF8 ADAR NUP205 ITPR3 RAD50 JUP EEF2 AHNAK PUM3 | 7.98e-06 | 652 | 179 | 14 | 31180492 | |
| Pubmed | SF3B4 NOP56 UGGT1 PRPF8 ADAR ERBIN NUP205 ITPR3 MYOF BRD2 TCERG1 AHNAK POLR1B PCID2 | 9.16e-06 | 660 | 179 | 14 | 32780723 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOP56 BMP2K RPS2 SMC1A PRPF8 ADAR ITPR3 JUP EEF2 CSE1L TCERG1 MTHFD1 NOM1 AHNAK POLR1B BCAR3 DDX41 | 9.17e-06 | 949 | 179 | 17 | 36574265 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.08e-05 | 202 | 179 | 8 | 33005030 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 1.09e-05 | 27 | 179 | 4 | 23027611 | |
| Pubmed | 1.10e-05 | 9 | 179 | 3 | 16382099 | ||
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 1.10e-05 | 9 | 179 | 3 | 33524014 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.12e-05 | 203 | 179 | 8 | 22083510 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.14e-05 | 268 | 179 | 9 | 33024031 | |
| Pubmed | RTEL1 SMC1A PRPF8 ADAR RAD50 MYOF TCERG1 MTHFD1 AHNAK POLR1B | 1.17e-05 | 340 | 179 | 10 | 24332808 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.24e-05 | 271 | 179 | 9 | 32433965 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | RPS2 NPEPPS RPS10 NUP205 EEF2 CSE1L MTHFD1 DIAPH1 RPS10P5 XPOT | 1.30e-05 | 344 | 179 | 10 | 36282215 |
| Pubmed | LGMN KLF12 NOP56 BMP2K UGGT1 PAK4 NUDT16L1 CHD7 ZNF318 ERBIN SPATA1 JUP MTHFD1 ARHGEF1 DIAPH1 DNM2 ARMC8 XPOT | 1.38e-05 | 1084 | 179 | 18 | 11544199 | |
| Pubmed | TANC2 CACNA1A IQSEC3 RPS2 NPEPPS RPS10 ERBIN STRIP1 JUP EEF2 CSE1L NF1 MTHFD1 ARHGEF1 DLG2 RPS10P5 CAMSAP2 DMTN DNM2 ARMC8 DNAH11 | 1.65e-05 | 1431 | 179 | 21 | 37142655 | |
| Pubmed | 1.85e-05 | 285 | 179 | 9 | 32838362 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 LGMN VWA8 MTHFD1L NPEPPS SMC1A PRPF8 STRIP1 EXOC8 NUP205 RAD50 MICU1 JUP CSE1L POLR1B DDX41 ARMC8 | 1.91e-05 | 1005 | 179 | 17 | 19615732 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DDX59 RPS2 CHD8 ZNF318 ADAR NUP205 ITPR3 PBRM1 NF1 POLR1B PUM3 | 1.94e-05 | 440 | 179 | 11 | 34244565 |
| Pubmed | NOP56 RPS2 MTHFD1L SMC1A PRPF8 MYOF JUP EEF2 CSE1L NF1 MTHFD1 NOM1 AHNAK TRPM1 TBCA | 1.94e-05 | 803 | 179 | 15 | 36517590 | |
| Pubmed | 1.96e-05 | 159 | 179 | 7 | 22751105 | ||
| Pubmed | NOP56 RPS2 SMC1A PAK4 LRRC40 THSD1 ERBIN JUP EEF2 C1orf198 CSE1L TCERG1 MTHFD1 AHNAK | 2.00e-05 | 708 | 179 | 14 | 39231216 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SF3B4 NOP56 RPS2 SMC1A RPS10 NUDT16L1 PRPF8 ADAR EEF2 TCERG1 RBM19 NOM1 PUM3 DDX41 TBCA | 2.06e-05 | 807 | 179 | 15 | 22681889 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH7 ILK BMP2K RPS6KA2 PAK4 RAD50 KSR1 MYOF NF1 BRD2 PIK3R2 DDX60L BCAR3 DDX41 DNM2 | 2.13e-05 | 910 | 179 | 16 | 36736316 |
| Pubmed | Interactomic analysis reveals a homeostatic role for the HIV restriction factor TRIM5α in mitophagy. | 2.24e-05 | 292 | 179 | 9 | 35545034 | |
| Pubmed | 2.34e-05 | 225 | 179 | 8 | 12168954 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 MYH7 ILK NOP56 RPS2 RPS10 CHD7 PRPF8 ADAR ITPR3 RAD50 EEF2 AHNAK | 2.40e-05 | 626 | 179 | 13 | 33644029 |
| Interaction | SIRT7 interactions | DCAF1 NOP56 RPS2 MTHFD1L NPEPPS UGGT1 RPS10 CHD8 CHD7 ZNF318 PRPF8 NUP205 ITPR3 RAD50 KAT2B PBRM1 CSE1L NF1 MTOR AHNAK PUM3 DNM2 XPOT | 2.01e-07 | 744 | 179 | 23 | int:SIRT7 |
| Interaction | NR2C2 interactions | DCAF1 TANC2 KLF12 SF3B4 NOP56 BMP2K RPS2 MTHFD1L SMC1A LRRC40 CHD8 NUDT16L1 CHD7 PRPF8 ADAR NUP205 EEF2 AP1S1 PBRM1 UBN1 TCERG1 MTHFD1 ARHGEF1 AHNAK DIAPH1 POLR1B CHD6 DDX41 PCID2 DNM2 XPOT | 2.16e-06 | 1403 | 179 | 31 | int:NR2C2 |
| Interaction | ITGB3 interactions | 2.96e-06 | 170 | 179 | 10 | int:ITGB3 | |
| Interaction | CTCF interactions | DCAF1 KLF12 NOP56 RPS2 SMC1A RPS10 CHD8 BRD3 CHD7 EEF2 BRD2 RBM19 NOM1 POLR1B PUM3 BRD1 | 3.80e-06 | 461 | 179 | 16 | int:CTCF |
| Interaction | EED interactions | CHL1 DCAF1 LGMN EPC2 NOP56 BMP2K RPS2 MTHFD1L SMC1A UGGT1 RPS10 LRRC40 NUDT16L1 CHD7 PRPF8 ADAR NUP205 RAD50 JUP EEF2 PBRM1 CSE1L TCERG1 MTHFD1 RBM19 NOM1 PUM3 DDX41 DNM2 XPOT | 1.11e-05 | 1445 | 179 | 30 | int:EED |
| Interaction | DUSP26 interactions | 1.38e-05 | 59 | 179 | 6 | int:DUSP26 | |
| Interaction | RICTOR interactions | RGPD4 ILK RPS6KA2 RGPD1 ERBIN TRIM10 NUP205 MYOF JUP EEF2 PBRM1 TCERG1 MTHFD1 MTOR NOM1 AHNAK RPS10P5 BRD1 ARMC8 XPOT | 1.44e-05 | 759 | 179 | 20 | int:RICTOR |
| Interaction | POLR1E interactions | NOP56 IFT81 CHD8 BRD3 CHD7 RAD50 PBRM1 BRD2 RBM19 NOM1 POLR1B CHD6 XPOT | 1.56e-05 | 350 | 179 | 13 | int:POLR1E |
| Interaction | EGLN3 interactions | DCAF1 LGMN PDPR ILK HGH1 BMP2K VWA8 MTHFD1L NPEPPS SMC1A UGGT1 LRRC40 CHD8 ZNF318 ERBIN NUP205 RAD50 EEF2 CSE1L MTHFD1 PIK3R2 NOM1 POLR1B CAMSAP2 DNM2 ARMC8 XPOT | 3.04e-05 | 1296 | 179 | 27 | int:EGLN3 |
| Interaction | POLR1G interactions | NOP56 SMC1A CHD9 CHD8 BRD3 CHD7 NUP205 RAD50 PBRM1 BRD2 RBM19 POLR1B PUM3 PCID2 XPOT | 3.27e-05 | 489 | 179 | 15 | int:POLR1G |
| Interaction | ANKRD55 interactions | 3.84e-05 | 228 | 179 | 10 | int:ANKRD55 | |
| Interaction | C9orf78 interactions | VWA8 MTHFD1L NPEPPS SMC1A IFT81 UGGT1 LRRC40 PRPF8 ADAR EXOC8 RAD50 CSE1L TCERG1 DIAPH1 PCID2 DNM2 XPOT | 4.00e-05 | 620 | 179 | 17 | int:C9orf78 |
| Interaction | BRD7 interactions | LGMN SF3B4 ILK NOP56 RPS2 SMC1A RGPD1 BRD3 CHD7 PRPF8 EEF2 PBRM1 BRD2 MTHFD1 PIK3R2 NOM1 DDX41 | 5.59e-05 | 637 | 179 | 17 | int:BRD7 |
| Interaction | RHOV interactions | 6.57e-05 | 243 | 179 | 10 | int:RHOV | |
| Interaction | TRIM10 interactions | 6.57e-05 | 48 | 179 | 5 | int:TRIM10 | |
| Interaction | STIP1 interactions | DDX59 SF3B4 ILK NOP56 RPS2 SMC1A RPS10 LRRC40 PRPF8 ADAR NUP205 RAD50 EEF2 CSE1L TCERG1 MTHFD1 MTOR AHNAK DIAPH1 DDX41 DNM2 XPOT | 8.85e-05 | 1006 | 179 | 22 | int:STIP1 |
| Interaction | PIH1D1 interactions | RPS2 MTHFD1L SMC1A UGGT1 KSR2 RPS10 LRRC40 PRPF8 RAD50 JUP EEF2 CSE1L MTHFD1 MTOR AHNAK POLR1B DDX41 XPOT | 9.39e-05 | 731 | 179 | 18 | int:PIH1D1 |
| Interaction | FBXO22 interactions | NOP56 HGH1 TOPAZ1 MTHFD1L NPEPPS IFT81 PCDHB6 CHD9 BRD3 AK9 PRPF8 PTPRB KIAA0825 MTHFD1 XPOT | 1.00e-04 | 540 | 179 | 15 | int:FBXO22 |
| Interaction | PPM1A interactions | 1.07e-04 | 163 | 179 | 8 | int:PPM1A | |
| Interaction | RHOF interactions | TANC2 ILK NPEPPS PAK4 TNFRSF10B ERBIN NUP205 MYOF JUP C1orf198 CSE1L UQCC3 MTOR PIK3R2 DIAPH1 MAD2L2 XPOT | 1.09e-04 | 673 | 179 | 17 | int:RHOF |
| Interaction | AXL interactions | SF3B4 SMC1A UGGT1 LRRC40 ERBIN NUP205 JUP PIK3R2 AHNAK PUM3 PCID2 XPOT | 1.19e-04 | 369 | 179 | 12 | int:AXL |
| Interaction | TWIST1 interactions | 1.43e-04 | 170 | 179 | 8 | int:TWIST1 | |
| Cytoband | 5q31 | 6.39e-06 | 115 | 179 | 6 | 5q31 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 3.62e-04 | 5 | 110 | 2 | 1157 | |
| GeneFamily | Phosphodiesterases | 4.04e-04 | 24 | 110 | 3 | 681 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.14e-04 | 26 | 110 | 3 | 253 | |
| GeneFamily | Exportins | 7.55e-04 | 7 | 110 | 2 | 547 | |
| GeneFamily | DEAD-box helicases | 2.12e-03 | 42 | 110 | 3 | 499 | |
| GeneFamily | EF-hand domain containing | 2.22e-03 | 219 | 110 | 6 | 863 | |
| GeneFamily | Myosin heavy chains | 3.66e-03 | 15 | 110 | 2 | 1098 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.69e-03 | 51 | 110 | 3 | 870 | |
| GeneFamily | Dyneins, axonemal | 4.70e-03 | 17 | 110 | 2 | 536 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.70e-03 | 17 | 110 | 2 | 104 | |
| GeneFamily | DNA helicases | 4.70e-03 | 17 | 110 | 2 | 1167 | |
| Coexpression | ODONNELL_METASTASIS_UP | 8.72e-07 | 76 | 178 | 7 | M265 | |
| Coexpression | GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN | 9.33e-06 | 199 | 178 | 9 | M3286 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN | 9.71e-06 | 200 | 178 | 9 | M5169 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.10e-06 | 161 | 173 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-06 | 189 | 179 | 8 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.43e-06 | 198 | 179 | 8 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 174 | 179 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 123 | 179 | 6 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 187 | 179 | 7 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 187 | 179 | 7 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 187 | 179 | 7 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.29e-05 | 192 | 179 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 179 | 7 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-05 | 197 | 179 | 7 | 383d598ce3f8f5fc98bef3300e4cf7b6992aec9c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.52e-05 | 197 | 179 | 7 | 3cc4e56a77f96a43f9b5a24cf1b9524c927ef795 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.65e-05 | 133 | 179 | 6 | d680c0cf37949aad7bdf04ff5093f005a8c982d6 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.68e-05 | 200 | 179 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 1.68e-05 | 200 | 179 | 7 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | COVID-19_Convalescent-PLT_3|World / Disease Group and Platelet Clusters | 1.95e-05 | 137 | 179 | 6 | bb54bb81b450462ad521b57e1a07a80ce1678e67 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.25e-05 | 150 | 179 | 6 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.50e-05 | 152 | 179 | 6 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.19e-05 | 157 | 179 | 6 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.71e-05 | 166 | 179 | 6 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 167 | 179 | 6 | 589c0acfeb4d70931b6726fb3331d85a54e74d56 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.11e-05 | 168 | 179 | 6 | 95dc690c1987b05685d36e6bb20eb79308696e30 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-05 | 169 | 179 | 6 | 5f5bec13208f4c3b6eacbba180c8a6402743b76e | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 170 | 179 | 6 | 12203d4410f38cc933d9f160b5fb76828df94119 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-05 | 170 | 179 | 6 | f9decb3bf3bf6d4996b0ac27af768236e116aac5 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.95e-05 | 172 | 179 | 6 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 179 | 6 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 178 | 179 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.67e-05 | 179 | 179 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | C_00|World / shred on cell type and cluster | 8.67e-05 | 179 | 179 | 6 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.67e-05 | 179 | 179 | 6 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 182 | 179 | 6 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 183 | 179 | 6 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 9.78e-05 | 183 | 179 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 9.78e-05 | 183 | 179 | 6 | c94ee9f35b21252e1ab5ab15b6a2ce69a7d753f7 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 184 | 179 | 6 | 226ccac00ac1c3a0ad7283785fd14312320e0ca6 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.01e-04 | 184 | 179 | 6 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 185 | 179 | 6 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 185 | 179 | 6 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-04 | 186 | 179 | 6 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 187 | 179 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 188 | 179 | 6 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 188 | 179 | 6 | ccd2541892112a7a303f766adf9a7afeb754498c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 190 | 179 | 6 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 190 | 179 | 6 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 190 | 179 | 6 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 191 | 179 | 6 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 191 | 179 | 6 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 191 | 179 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 191 | 179 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 191 | 179 | 6 | 81f77bf497b8e0ae0affe7d5f4f00446547229f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 192 | 179 | 6 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 192 | 179 | 6 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.27e-04 | 192 | 179 | 6 | 9a2560921b8c0997e1788053004f099439e8f071 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 179 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 179 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 179 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 179 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.35e-04 | 194 | 179 | 6 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 194 | 179 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-04 | 195 | 179 | 6 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-04 | 195 | 179 | 6 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 1.42e-04 | 196 | 179 | 6 | 9cc517373ce4374140ab153edc87ec5517ee1f63 | |
| ToppCell | NS-moderate-d_16-33|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.42e-04 | 196 | 179 | 6 | 85301941e0c04a237b307f56c87dc06760015a5d | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.42e-04 | 196 | 179 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 1.46e-04 | 197 | 179 | 6 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 197 | 179 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.46e-04 | 197 | 179 | 6 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_2|COVID-19_Mild / Disease condition and Cell class | 1.46e-04 | 197 | 179 | 6 | e844f660010d114d65bd814f3d3fccd8e4a6b8da | |
| ToppCell | COVID-19_Severe-CD4+_T_naive|COVID-19_Severe / Disease condition and Cell class | 1.46e-04 | 197 | 179 | 6 | ac26672bd2cb3bc9a11206d8da203bafec3931f6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-04 | 198 | 179 | 6 | e1a0c809302a3b304775bd708201ad412a98d711 | |
| ToppCell | NS-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 198 | 179 | 6 | e56417073e83061a43b9c41d6232d653904c1e90 | |
| ToppCell | NS-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 198 | 179 | 6 | 58f2bc88d92550fb0b7c2e46c63c49ec6777001c | |
| ToppCell | NS-critical-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 198 | 179 | 6 | fd5dd6d6d72356d4eac8637350405c69ccb7161c | |
| ToppCell | NS-critical-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 198 | 179 | 6 | 5602a78068ab6cccd4da1cc5566e68805820a295 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-04 | 199 | 179 | 6 | de9c1c801eb34faf01760df07d5ff6bbd561e152 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 199 | 179 | 6 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.55e-04 | 199 | 179 | 6 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | mild-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.55e-04 | 199 | 179 | 6 | ca319976a7d2576186d0a98cdc93e4c2d5fe8a05 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-04 | 199 | 179 | 6 | 45e2f44a0ed39cb9ba061a03874c1fe746856c2d | |
| ToppCell | 390C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-04 | 199 | 179 | 6 | 1a691dbf3da26f5450bde428a7c886dbc4834c81 | |
| ToppCell | Transverse-(4)_Monocyte|Transverse / shred on region, Cell_type, and subtype | 1.59e-04 | 200 | 179 | 6 | 85714e8da539366b5bce071dfea8f8055de527bc | |
| ToppCell | Transverse-Monocyte-Monocyte|Transverse / Region, Cell class and subclass | 1.59e-04 | 200 | 179 | 6 | 96ecfab57e998134e164b4a62881ef6f2612bd8d | |
| ToppCell | Transverse-Monocyte|Transverse / Region, Cell class and subclass | 1.59e-04 | 200 | 179 | 6 | d70aeb57b98496474b97906505576640fdbdf34c | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-04 | 200 | 179 | 6 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.59e-04 | 200 | 179 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 1.59e-04 | 200 | 179 | 6 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-04 | 200 | 179 | 6 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Transverse-(4)_Monocyte-(40)_Monocyte|Transverse / shred on region, Cell_type, and subtype | 1.59e-04 | 200 | 179 | 6 | 0187a4b1d2c3c89b7769d632e6d88190a06b093e | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.59e-04 | 200 | 179 | 6 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| Drug | Dfj | 7.15e-07 | 10 | 177 | 4 | CID009549198 | |
| Drug | AC 110 | 1.84e-06 | 4 | 177 | 3 | CID000022860 | |
| Drug | Bay K 8644 | 2.74e-06 | 150 | 177 | 9 | CID000002303 | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | DCAF1 EPHX2 CACNA1A VWA8 ERAP1 ABCA12 RAPGEF1 CSE1L NF1 IL1B | 3.14e-06 | 195 | 177 | 10 | 6215_UP |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | MYOZ3 TNFRSF10B KSR1 ZSCAN32 MYOF NF1 PDE8B RBM19 PIK3R2 DMTN | 3.29e-06 | 196 | 177 | 10 | 5016_DN |
| Drug | butamben | 4.51e-06 | 15 | 177 | 4 | CID000002482 | |
| Drug | 3-7a | 8.32e-06 | 36 | 177 | 5 | CID011987860 | |
| Drug | 3,4-dihydroquinazoline | 9.08e-06 | 6 | 177 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 9.08e-06 | 6 | 177 | 3 | CID000133976 | |
| Drug | APMPA | 1.58e-05 | 7 | 177 | 3 | CID000512300 | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 2.29e-05 | 195 | 177 | 9 | 7237_UP | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 2704_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 177 | 9 | 6455_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.58e-05 | 198 | 177 | 9 | 4620_DN | |
| Drug | C13932 | 3.52e-05 | 206 | 177 | 9 | CID000168297 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.94e-08 | 7 | 173 | 4 | DOID:0050834 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.98e-07 | 3 | 173 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 7.89e-07 | 4 | 173 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 6.81e-06 | 7 | 173 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | MASA syndrome (implicated_via_orthology) | 6.81e-06 | 7 | 173 | 3 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 5.07e-05 | 111 | 173 | 6 | C1621958 | |
| Disease | frontal fibrosing alopecia | 1.82e-04 | 48 | 173 | 4 | EFO_0009855 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.47e-04 | 148 | 173 | 6 | C0279702 | |
| Disease | Disorder of eye | 2.66e-04 | 212 | 173 | 7 | C0015397 | |
| Disease | Intellectual Disability | CHL1 TANC2 CACNA1B CACNA1E IQSEC3 CHD8 NF1 TRPM3 MTOR DIAPH1 | 3.26e-04 | 447 | 173 | 10 | C3714756 |
| Disease | Hypertrophic Cardiomyopathy | 3.54e-04 | 57 | 173 | 4 | C0007194 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 4.14e-04 | 25 | 173 | 3 | C4551472 | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 5.05e-04 | 6 | 173 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 5.22e-04 | 27 | 173 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Developmental Academic Disorder | 6.47e-04 | 29 | 173 | 3 | C1330966 | |
| Disease | Learning Disorders | 6.47e-04 | 29 | 173 | 3 | C0023186 | |
| Disease | Learning Disturbance | 6.47e-04 | 29 | 173 | 3 | C0751263 | |
| Disease | Adult Learning Disorders | 6.47e-04 | 29 | 173 | 3 | C0751262 | |
| Disease | Learning Disabilities | 6.47e-04 | 29 | 173 | 3 | C0751265 | |
| Disease | Epileptic encephalopathy | 7.16e-04 | 30 | 173 | 3 | C0543888 | |
| Disease | congenital heart disease (implicated_via_orthology) | 7.33e-04 | 69 | 173 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | neural tube defect (is_implicated_in) | 9.35e-04 | 8 | 173 | 2 | DOID:0080074 (is_implicated_in) | |
| Disease | Retinitis pigmentosa | 9.54e-04 | 74 | 173 | 4 | cv:C0035334 | |
| Disease | Glioblastoma | 1.22e-03 | 79 | 173 | 4 | C0017636 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.49e-03 | 10 | 173 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 1.53e-03 | 84 | 173 | 4 | C0334588 | |
| Disease | venous thromboembolism | 1.64e-03 | 460 | 173 | 9 | EFO_0004286 | |
| Disease | feeling nervous measurement | 1.74e-03 | 87 | 173 | 4 | EFO_0009597 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.79e-03 | 41 | 173 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Macrocephaly | 1.82e-03 | 11 | 173 | 2 | C0221355 | |
| Disease | Seizures | 1.86e-03 | 218 | 173 | 6 | C0036572 | |
| Disease | Childhood Medulloblastoma | 2.06e-03 | 43 | 173 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.06e-03 | 43 | 173 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 2.06e-03 | 43 | 173 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.06e-03 | 43 | 173 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.06e-03 | 43 | 173 | 3 | C0278876 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.07e-03 | 152 | 173 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Lenticulostriate Disorders | 2.17e-03 | 12 | 173 | 2 | C0750951 | |
| Disease | Night blindness, congenital stationary, type 1 | 2.17e-03 | 12 | 173 | 2 | C3501847 | |
| Disease | Extrapyramidal Disorders | 2.17e-03 | 12 | 173 | 2 | C0015371 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 2.17e-03 | 12 | 173 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 2.17e-03 | 12 | 173 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 2.17e-03 | 12 | 173 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 2.17e-03 | 12 | 173 | 2 | C3711543 | |
| Disease | Trigeminal Neuralgia | 2.17e-03 | 12 | 173 | 2 | C0040997 | |
| Disease | distal myopathy (implicated_via_orthology) | 2.17e-03 | 12 | 173 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.17e-03 | 12 | 173 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 2.17e-03 | 12 | 173 | 2 | C1848172 | |
| Disease | Secondary Trigeminal Neuralgia | 2.17e-03 | 12 | 173 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 2.17e-03 | 12 | 173 | 2 | C0393786 | |
| Disease | Basal Ganglia Diseases | 2.17e-03 | 12 | 173 | 2 | C0004782 | |
| Disease | Gastric Adenocarcinoma | 2.35e-03 | 45 | 173 | 3 | C0278701 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.55e-03 | 13 | 173 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.55e-03 | 13 | 173 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.55e-03 | 13 | 173 | 2 | C0410203 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.55e-03 | 13 | 173 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, 1 | 2.55e-03 | 13 | 173 | 2 | C4551952 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.55e-03 | 13 | 173 | 2 | C4041558 | |
| Disease | Congenital Structural Myopathy | 2.55e-03 | 13 | 173 | 2 | C0752282 | |
| Disease | epilepsy (implicated_via_orthology) | 2.80e-03 | 163 | 173 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.82e-03 | 48 | 173 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.97e-03 | 14 | 173 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 2.97e-03 | 14 | 173 | 2 | C0410207 | |
| Disease | Medulloblastoma | 3.17e-03 | 50 | 173 | 3 | C0025149 | |
| Disease | Retinitis Pigmentosa | 3.33e-03 | 104 | 173 | 4 | C0035334 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.41e-03 | 15 | 173 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.41e-03 | 15 | 173 | 2 | C3645536 | |
| Disease | Optic Atrophy, Hereditary, Leber | 3.41e-03 | 15 | 173 | 2 | C0917796 | |
| Disease | Epilepsy | 3.94e-03 | 109 | 173 | 4 | C0014544 | |
| Disease | S-adenosylhomocysteine measurement | 4.39e-03 | 17 | 173 | 2 | EFO_0010531 | |
| Disease | Night blindness, congenital stationary | 4.39e-03 | 17 | 173 | 2 | C0339535 | |
| Disease | Drug habituation | 4.76e-03 | 115 | 173 | 4 | C0013170 | |
| Disease | Drug abuse | 4.76e-03 | 115 | 173 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.76e-03 | 115 | 173 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 4.76e-03 | 115 | 173 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 4.76e-03 | 115 | 173 | 4 | C0013222 | |
| Disease | Drug Dependence | 4.76e-03 | 115 | 173 | 4 | C1510472 | |
| Disease | Substance Dependence | 4.76e-03 | 115 | 173 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 4.76e-03 | 115 | 173 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.76e-03 | 115 | 173 | 4 | C0029231 | |
| Disease | neutrophil-to-lymphocyte ratio | 4.79e-03 | 185 | 173 | 5 | EFO_0008447 | |
| Disease | Substance abuse problem | 4.91e-03 | 116 | 173 | 4 | C0740858 | |
| Disease | Child Behaviour Checklist assessment | 4.92e-03 | 18 | 173 | 2 | EFO_0005661 | |
| Disease | kidney volume | 4.92e-03 | 18 | 173 | 2 | EFO_0600044 | |
| Disease | Congenital Fiber Type Disproportion | 4.92e-03 | 18 | 173 | 2 | C0546264 | |
| Disease | Polydactyly | 5.06e-03 | 117 | 173 | 4 | C0152427 | |
| Disease | response to cranial radiation therapy, short-term memory | 5.31e-03 | 60 | 173 | 3 | EFO_0004335, EFO_0010950 | |
| Disease | cardiomyopathy (is_implicated_in) | 5.47e-03 | 19 | 173 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | hearing threshold measurement, hearing measurement | 5.56e-03 | 61 | 173 | 3 | EFO_0007616, EFO_0007618 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKSIMKAMIPLLQIG | 216 | O00555 | |
| LELRENQLKMLPKTM | 166 | Q96RT1 | |
| KLETLPEEMGDMQKL | 356 | Q96RT1 | |
| KMEIKPLQFEIMIDR | 131 | Q52LR7 | |
| MVPLGIDETIDKLKM | 1006 | O95696 | |
| IIKNPMDMGTIKKRL | 76 | Q15059 | |
| RLQLKDMIPTEMQRL | 551 | Q92888 | |
| EVPGDLMAKRMSLIL | 76 | Q5SNV9 | |
| LQAILKPMMLRRLKE | 1021 | Q9HCK8 | |
| KPMMLRRLKEDVEKN | 1026 | Q9HCK8 | |
| KQEDPKKEILLAMLM | 121 | Q96GE6 | |
| LKSIMKAMVPLLQIG | 211 | Q15878 | |
| MKALEMPQITRLEKT | 651 | O75815 | |
| KPVEKMMELFIRLKE | 661 | Q86UK0 | |
| MPSMLERISKNLVKE | 1 | Q9BYG8 | |
| RMKVSIPTKALELMD | 851 | Q9BXX3 | |
| MVRELMQVVLARKPK | 31 | P61966 | |
| MILGKMVLQLSKEPS | 211 | Q92600 | |
| MELLLEKGKPLMLVG | 2496 | Q96DT5 | |
| MNIKAPKISMPDIDL | 3536 | Q09666 | |
| MNIKAPKISMPDIDL | 3866 | Q09666 | |
| KQMPEPEQLKMLSEL | 896 | O60610 | |
| MPDLNVCKREITIMK | 86 | Q9NSY1 | |
| VLMKDAIKPNLMQTL | 656 | Q6UB35 | |
| NQRKLPKDMMPRILE | 181 | Q6DHV5 | |
| VVLKSIMKAMVPLLQ | 211 | Q00975 | |
| QKLQAILKPMMLRRL | 1176 | Q9P2D1 | |
| ILKPMMLRRLKEDVE | 1181 | Q9P2D1 | |
| KPEDIQMITELKAML | 986 | Q8NB25 | |
| TLKKNPRDRMMLLKL | 161 | Q9Y2K5 | |
| PRDRMMLLKLEQEIL | 166 | Q9Y2K5 | |
| SRLLEDNMKPMLKKR | 636 | Q09MP3 | |
| MRKPDSKIVLLGDMN | 1 | Q9NX57 | |
| MSRLIVKNLPNGMKE | 1 | Q9Y4C8 | |
| VMLLQGIVQKPELEM | 161 | Q96DM1 | |
| KKEKRRDEMLGLVPM | 721 | Q92878 | |
| KLELIMDEMKQILTP | 301 | Q15397 | |
| MVAKGRAILLPMDLD | 1531 | Q14573 | |
| IDLIEKPMGIMSILE | 521 | P12883 | |
| ITDFLALMPMKVKQL | 396 | Q92621 | |
| ISERDPMMQKLIILV | 631 | Q9Y5F3 | |
| QEMERLTLDLMKPKS | 206 | Q8IZ07 | |
| MVPILTRMSQLIEKE | 31 | Q9Y4B6 | |
| LKNLEPKMIELIMNE | 376 | Q6PIW4 | |
| SVVVAMDKLRKMLVP | 66 | P01584 | |
| GEIPRKNLDVMKEAM | 411 | O00567 | |
| EKSLLNIMMLVPHKR | 1406 | P23467 | |
| PIDLMKIQQKLKMEE | 91 | Q86U86 | |
| EMSEVQLMRLLPIKK | 221 | Q9NPJ1 | |
| LIPLKTMTSDILKMQ | 186 | Q9UI95 | |
| NLMKEMTKKPIFLVL | 566 | Q8IV33 | |
| LRTIVQKMPMKLTVN | 211 | O00533 | |
| MKKNGMRFILILDPA | 1261 | Q2M2H8 | |
| KKPRVMGDIPMELIN | 441 | Q92831 | |
| DPMKDILILSALRQM | 411 | Q53G44 | |
| MKADGMRVILILDPA | 2201 | O43451 | |
| FTKLMDMLEKLPKRN | 921 | Q6VAB6 | |
| AKELMSGLPRMKTVL | 291 | Q5T1V6 | |
| VKMFPLLVEKLRQMD | 1091 | Q5H9U9 | |
| LTALLPSVKEDKMLM | 36 | Q9UBQ6 | |
| LSPMARKIMQDKEKI | 36 | Q9H425 | |
| CRMERKLMLQEPLEK | 61 | Q49B96 | |
| IMKQRLMRGLEKPKD | 436 | Q9BPX6 | |
| GLNELIPMYKLMEKR | 676 | Q9NZ08 | |
| EEMVLRLQKEAMVKP | 31 | Q8N4E4 | |
| FPLDLDVKMKAVMIG | 281 | O15162 | |
| SLLMDMLEKLPKLNR | 871 | Q8IVT5 | |
| KMLSKEELPQRKMCL | 301 | Q9UGF5 | |
| RRMPELETLEIMKLV | 341 | Q8NCN5 | |
| IPMMDRNKAAELPKL | 756 | P35913 | |
| IPMMDRNKRDELPKL | 761 | P51160 | |
| PENQILIKRMMIKCA | 766 | O95263 | |
| EPSMMLLENVKRHLK | 111 | Q6UXP7 | |
| MKNPMLEVVSLLLEK | 1 | O95237 | |
| QIMSNKKPDLIEMLL | 291 | P12882 | |
| KMLIPQLKESLQTLM | 61 | Q9NX70 | |
| PQDDLMLIKLAKPAM | 96 | A4D1T9 | |
| PGRLMDLLQKKMVSL | 321 | Q9UJV9 | |
| IINKSIRDLMPKTIM | 666 | P50570 | |
| RRMNLMTPEALGKLK | 576 | Q8IYI6 | |
| PNIKPDRKMMLEDFI | 796 | Q9UPP2 | |
| KMAVRLADGLQKMVP | 261 | P14923 | |
| PNMLEILKEMNSVKL | 236 | Q15390 | |
| IDKRMNSLKPDLMQL | 556 | O00459 | |
| KNKRMILIYLLPVKM | 246 | Q5JVF3 | |
| ELIPLAKEMMAQKRK | 6 | P27469 | |
| LLMSLLPRNVAMEMK | 266 | Q08828 | |
| LMILKKDAMSLVNPL | 171 | O95704 | |
| VKMLQRDKPIEMQLT | 241 | Q8IUR7 | |
| QVQKLQAILKPMMLR | 1066 | Q3L8U1 | |
| QAILKPMMLRRLKED | 1071 | Q3L8U1 | |
| PMMLRRLKEDVEKKL | 1076 | Q3L8U1 | |
| LIEKKMMRNEPIEGK | 326 | Q8WYA0 | |
| INRPMLQAALMLRKK | 101 | P34913 | |
| LMLKTPSLKGLMEAI | 546 | Q9NZI5 | |
| ESMMPNKVRKIGELV | 706 | P55265 | |
| RELIEKMIAMDPQKR | 806 | O75460 | |
| PRIELKEMENKLPME | 211 | Q6ZN84 | |
| EQVKKLQSILKPMML | 666 | Q8TD26 | |
| LQSILKPMMLRRLKD | 671 | Q8TD26 | |
| EMKPVLKQRMSEFLK | 1186 | Q2V2M9 | |
| RPKFDMIVPILEKMQ | 436 | Q13418 | |
| FLILPMERKMSLLKQ | 126 | Q7Z7H3 | |
| LTPLLSVVRNMEMEK | 156 | Q9Y5Q5 | |
| PKDILTLRLDVMMET | 161 | P10253 | |
| MRKLMASIVLDELQP | 446 | Q9Y2E5 | |
| LMLDGMPAVRVKTEL | 21 | Q9Y4X4 | |
| MLDMEFEPQIRKILL | 381 | Q86TM3 | |
| IKPRSLEPLMEMNKR | 796 | Q15700 | |
| IKPVLMMNKMDRALL | 151 | P13639 | |
| KLNLVAPAIKERMMK | 461 | Q6ZQY3 | |
| MILKEEMEKSLPIRR | 251 | Q08495 | |
| EPLQRMFEKLINKML | 2251 | Q9P225 | |
| MQKLEMLRIKEPLHF | 261 | Q8N7B9 | |
| KLKILMDKPEMNVVL | 556 | P55786 | |
| LTVLMKDAIKPNLMQ | 611 | P11586 | |
| QLKLMEDMDTVIKPR | 1241 | Q08AD1 | |
| LKFKDPLLMKMIRNI | 476 | Q92845 | |
| QLCEIPKRMVELKEM | 436 | Q9H9A6 | |
| LKAMKMIRDNLPPRL | 521 | O96013 | |
| ILKNEVNGKPRMLMR | 1071 | P0DJD0 | |
| PDADIRKMLVEAIML | 281 | Q9BTY7 | |
| ITRIPKMLTANKMKL | 316 | Q96E29 | |
| EMLLKISEITMPGKI | 136 | Q9Y5E3 | |
| VMPFLRKMLIQILTE | 726 | P42345 | |
| VLAEEKEVPMMRKGL | 516 | Q8N807 | |
| PGLNMELEDIAKLKM | 306 | Q9NZ71 | |
| KPAEELFMIVMDRLK | 271 | Q5TCS8 | |
| KILKNEVNGKPRMLM | 1086 | Q7Z3J3 | |
| LEPKLKKILQMNPRM | 106 | O75677 | |
| ELGLPRKQSEMQMKA | 276 | Q6NUJ1 | |
| TNKRKIMLLSDPEME | 261 | Q9UPU3 | |
| PLIENGMIERMIEKL | 166 | Q9Y6C5 | |
| PILKRALKVKQAMMQ | 696 | Q5VSL9 | |
| KPDIMIILLSKLMEE | 1236 | Q9HCD6 | |
| METMGKRILPILDFI | 426 | Q9BXB7 | |
| TMLALKNNDMRKIPG | 551 | Q5C9Z4 | |
| VMAKDRLQLLEKMQP | 186 | Q9UBP0 | |
| MQLEAREIKMRPKNL | 376 | Q5VX52 | |
| GVPQMMLQLEKKLER | 161 | Q6P4H8 | |
| IIKQPMDMGTIKRRL | 116 | P25440 | |
| DIMSLKRMLEKLGVP | 66 | P55008 | |
| LLLMIERGILAEMKP | 56 | Q8NCH0 | |
| DIKMPLRKHNLELTM | 81 | Q86WS4 | |
| LMVQLPDKMRLDLAI | 936 | Q14028 | |
| MMPEGIKQNKARTIL | 696 | Q6P2Q9 | |
| MLMPKKNRIAIYELL | 1 | P46783 | |
| GERRKQEMLKEMPLQ | 31 | Q6UW78 | |
| LQLVLGPTLVMDIKM | 11 | Q5GAN3 | |
| KMFGMVLEKIIIPEI | 816 | P55060 | |
| SEKDLKVLMKEMAPL | 126 | Q9NX65 | |
| KVLMKEMAPLGATRE | 131 | Q9NX65 | |
| MLMPKKNRIAIHELL | 1 | Q9NQ39 | |
| VDKMAIDKKVLEMLP | 111 | Q13905 | |
| IVPLEARMKQFKDML | 656 | O14776 | |
| LRAMKRLLKMPADQL | 346 | Q8NE28 | |
| ALKVLNMMPEEKLVE | 176 | Q9BRJ7 | |
| EKMREILMSEPGKLL | 941 | Q9HCF6 | |
| MKPMLKDFSNLLLVV | 1 | Q9NS62 | |
| TMRLDETMLVKQLLP | 101 | P21359 | |
| VLQRIAAPNMKAMEK | 1016 | Q14683 | |
| LEPKLKKILQMNPRM | 106 | O75679 | |
| PLMRKLGLMDNEIKV | 356 | O14763 | |
| LRMRKNPGLKVIMGI | 741 | Q7Z4N2 | |
| LEQGRKPLTMKRNEM | 56 | Q68DY1 | |
| IVNLSIMVKMLPSLK | 1186 | Q8N9V7 | |
| IMVKMLPSLKILLNI | 1191 | Q8N9V7 | |
| QALPLQREMKMFLEK | 286 | Q9UDY6 | |
| QKLKEAIGRAMPEQM | 446 | Q9NPG3 | |
| LMRNLLTPLMEKFKI | 616 | O43592 | |
| ELRRLMMSKENMKLP | 121 | Q15819 | |
| QSKDIIPLVMEMKRG | 876 | Q9UI33 | |
| PLMKEMLKRFQVAVN | 296 | Q9C037 | |
| IINGIEKVIRMLIMP | 171 | Q9H9Y6 | |
| MPVTKLGRLVKDMKI | 61 | P15880 | |
| LLPKEIVKVEKMMEN | 371 | A3KMH1 | |
| QDLFPKVMKKMRVPI | 436 | Q9UN76 | |
| KKQAEILQESRMMIP | 51 | O75347 | |
| ILKKRIEVDIMEPSM | 381 | Q5VUA4 | |
| IKIMNMIKLYGKPIR | 71 | Q15427 | |
| LRIMMLSVLKNTKTP | 1271 | Q9NYU2 | |
| MEGERLQPKMVKSLK | 516 | Q5TIE3 | |
| DLSAKQKMPEIRMAL | 201 | Q96A05 | |
| MAQQNMKVRPVLLKR | 1 | A6NMK8 | |
| VLMMLLRPLLVKKIA | 166 | Q9P055 | |
| ETMALILKAKLGMPQ | 266 | Q15349 | |
| PLTIMKRKLMNTNDL | 311 | Q99538 | |
| LDMIPDLKAMNPLKA | 1921 | Q9NZM1 | |
| ELQMPDIMRLITKDL | 221 | Q147X3 | |
| LGKKLSVPQDLMMEE | 26 | Q8TDC0 | |
| LLMKRKELIPLVVFM | 6 | Q9C002 |